Researchers identify a possible cause and treatment for inflammatory bowel disease

Inflammatory bowel disease (IBD) is a category of refractory inflammatory disease, of which ulcerative colitis (UC) and Crohn’s disease (CD) are the main types. Current studies suggest that IBD is a complex autoinflammatory disease determined by genetic and environmental factors, and is the major cause of gastrointestinal cancer. Because of its complex and refractory character, researchers have focused on determining […]

Continue reading »

The high cost challenge of personalised screening for bowel cancer

Personalised screening could improve the diagnosis of bowel cancer and re-shape the future of Australia’s National Bowel Cancer Screening Program (NBCSP), according to new research at The University of Western Australia. The study, published today in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research, hopes to improve health outcomes by targeting screening at those […]

Continue reading »

Therapy adherence for inflammatory bowel disease lower in the educated

(HealthDay)—Nonadherence to inflammatory bowel disease (IBD) treatment is more common among wealthier, more educated patients, according to a study published online March 18 in JGH Open. Sanjeevani K. Tomar, from the All India Institute of Medical Sciences in New Delhi, and colleagues sought to identify the rates and predictors of nonadherence to medications in IBD among 266 patients (204 with […]

Continue reading »